Slide 1Bridging Studies Global Development W. Joe Shih Biostatistics Dept UMDNJ-School of Public Health Sept. 29, 2006 FDA/Industry Conference, Washington D.C. Slide 2 Clarification…

1.Design and Conduct Safety Pharmacology & Toxicology Study for Pharmaceuticals Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Professor of Pharmaceutics Department of Pharmaceutics,…

Open Information Day â 22 October 2010 - Brussels Martin Pan, MD EFPIA Coordinator Improving the preclinical models and tools for tuberculosis medicines research Open Information…

1. THE NEXT GENERATION IN CLINICAL RESEARCH Q1 2015 2. Sanguine is bridging the gap between patients and pharmas in the clinical R&D process by developing a novel @home…

Slide 1 Slide 2 Hepatic generation of active metabolite Pharmacogenetics of Cardiovascular Antithrombotic Therapy CYP = cytochrome P450. GP = glycoprotein. MDR = multidrug…

Use of Modelling for PKPD Studies in Infectious Diseases Joe Standing Infectious Diseases and Microbiology Unit UCL Institute of Child Health, London ESPID May 2012 * Outline…

Slide 1 Hepatic generation of active metabolite Pharmacogenetics of Cardiovascular Antithrombotic Therapy CYP = cytochrome P450. GP = glycoprotein. MDR = multidrug resistance…